Literature DB >> 1928973

Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis.

P D Snashall1, K F Chung.   

Abstract

Small and large airways narrow in LVF and the term cardiac asthma is often used. However, current usage of this term is inconsistent and its meaning is therefore ambiguous. The term is better avoided despite several emerging similarities with bronchial asthma. Airway narrowing may be precipitated by acute elevation of pulmonary or bronchial vascular pressures. This appears to be mainly due to reflex bronchoconstriction. The afferents of this reflex are C-fibers with their endings in the lung parenchyma, bronchi, and pulmonary blood vessels and RAR in the larger airways, and they run in the vagus nerves, as do the efferent bronchoconstrictor fibers. Chronic elevation of pulmonary vascular pressures, as in mitral stenosis, are also associated with airway narrowing. Pulmonary edema (in the absence of vascular hypertension) also causes reflex bronchoconstriction. Bronchial responsiveness to bronchoconstrictor drugs is increased in LVF, partly, at least, due to reflex mechanisms. Bronchial mucosal swelling may also contribute. Narrowing by nonreflex mechanisms definitely occurs and there is direct evidence that decreased lung volume caused by pulmonary edema may cause this. There is little evidence for bronchial narrowing due to the mechanical effect of peribronchial edema, or by swelling of the bronchial mucosa. However, edema foam may terminally cause grave obstruction. Patients with LVF are commonly treated with bronchodilator drugs, but the basis for this approach needs further clarification.

Entities:  

Mesh:

Year:  1991        PMID: 1928973     DOI: 10.1164/ajrccm/144.4.945

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

Review 1.  Obstructive sleep apnea syndrome and asthma: what are the links?

Authors:  Michel Alkhalil; Edward Schulman; Joanne Getsy
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

2.  Pulmonary Oedema-Therapeutic Targets.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Mihai Gheorghiade; Gerasimos Filippatos
Journal:  Card Fail Rev       Date:  2015-04

Review 3.  The epidemiology and therapy of airflow limitation in the elderly.

Authors:  L Dow
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

4.  Prevention of airway hyperresponsiveness induced by left ventricular dysfunction in rats.

Authors:  Ferenc Petak; Gergely Albu; Eniko Lele; Maurice Beghetti; Walid Habre
Journal:  Respir Res       Date:  2012-12-13

Review 5.  Asthma and Obstructive Sleep Apnea.

Authors:  Yi-Xian Qiao; Yi Xiao
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

6.  Respiratory sound energy and its distribution patterns following clinical improvement of congestive heart failure: a pilot study.

Authors:  Zhen Wang; Brigitte M Baumann; Karen Slutsky; Karen N Gruber; Smith Jean
Journal:  BMC Emerg Med       Date:  2010-01-15

7.  Cardiac asthma in elderly patients: incidence, clinical presentation and outcome.

Authors:  Stéphane Jorge; Marie-Hélène Becquemin; Samuel Delerme; Mohamed Bennaceur; Richard Isnard; Rony Achkar; Bruno Riou; Jacques Boddaert; Patrick Ray
Journal:  BMC Cardiovasc Disord       Date:  2007-05-14       Impact factor: 2.298

8.  Relationship between atrial septal defects and asthma-like dyspnoea: the impact of transcatheter closure.

Authors:  M Nassif; C B B C Heuschen; H Lu; B J Bouma; R P van Steenwijk; P J Sterk; B J M Mulder; R J de Winter
Journal:  Neth Heart J       Date:  2016-11       Impact factor: 2.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.